https://old.journalforclinicalstudies.com/how-to-ensure-supply-when-sourcing-innovator-products-for-biosimilar-research-and-trials-2/ 2013-04-11T09:05:46+00:00 https://old.journalforclinicalstudies.com/investigating-outbreaks-of-novel-infectious-disease-an-international-case-study-3/ 2013-04-11T09:00:00+00:00 https://old.journalforclinicalstudies.com/serious-adverse-events-sae-audit-of-an-oncology-clinical-trial-2/ 2013-04-11T08:58:42+00:00 https://old.journalforclinicalstudies.com/china-part-of-the-critical-path-in-drug-development-in-the-21st-century-2/ 2013-04-10T15:33:34+00:00 https://old.journalforclinicalstudies.com/tunisia-a-focus-on-the-clinical-trials-landscape-2/ 2013-04-10T15:29:24+00:00 https://old.journalforclinicalstudies.com/fda-inspection-close-up-using-strong-process-mapping-and-gap-analysis-2/ 2013-04-10T15:19:56+00:00 https://old.journalforclinicalstudies.com/risk-mitigation-and-due-diligence-in-overcoming-lost-to-follow-up-ltfu-subjects-in-a-clinical-trial-2/ 2013-04-10T15:14:44+00:00 https://old.journalforclinicalstudies.com/enhancement-of-regulatory-procedures-on-medicinal-products-in-serbia-patients-information-requirements/ 2013-04-10T15:07:49+00:00 https://old.journalforclinicalstudies.com/health-economics-and-multinational-randomised-controlled-trials-2/ 2013-04-10T14:59:26+00:00 https://old.journalforclinicalstudies.com/improving-transition-of-investigational-medicines-in-alzheimers-disease-from-phase-i-to-phase-ii-2/ 2013-02-15T11:16:14+00:00 https://old.journalforclinicalstudies.com/cell-based-testing-in-central-laboratories/ 2013-02-08T16:41:30+00:00 https://old.journalforclinicalstudies.com/managing-your-risk-in-the-safe-transportation-of-life-saving-pharmaceuticals-active-versus-passive-in-the-distribution-supply-chain/ 2013-02-08T16:36:35+00:00 https://old.journalforclinicalstudies.com/challenges-in-conducting-tuberculosis-clinical-trials-in-developing-countries-lessons-learned/ 2013-02-08T16:27:21+00:00 https://old.journalforclinicalstudies.com/developing-analgesia-studies-use-of-placebo-control-in-the-eu/ 2013-02-08T16:18:50+00:00 https://old.journalforclinicalstudies.com/development-of-new-diabetes-drugs-implications-for-clinical-practice/ 2013-02-08T16:09:42+00:00 https://old.journalforclinicalstudies.com/clinical-trials-in-russia-report-of-the-3rd-quarter-2012/ 2013-02-08T14:53:56+00:00 https://old.journalforclinicalstudies.com/developing-of-clinical-trials-in-the-republic-of-moldova/ 2013-02-08T14:49:13+00:00 https://old.journalforclinicalstudies.com/three-key-drivers-of-clinical-study-costs/ 2013-02-08T14:41:44+00:00 https://old.journalforclinicalstudies.com/pulling-the-trigger-on-risk-based-monitoring/ 2013-02-08T14:34:18+00:00 https://old.journalforclinicalstudies.com/cardiovascular-safety-watch-column-3/ 2013-02-08T14:26:08+00:00 https://old.journalforclinicalstudies.com/new-incentives-for-antibiotic-development/ 2013-02-08T14:22:59+00:00 https://old.journalforclinicalstudies.com/1527/ 2013-02-06T15:49:27+00:00 https://old.journalforclinicalstudies.com/generics-bid-the-user-fee-free-era-farewell/ 2012-11-30T16:46:32+00:00 https://old.journalforclinicalstudies.com/cardiovascular-safety-watch-column-2/ 2012-11-30T16:45:06+00:00 https://old.journalforclinicalstudies.com/the-role-of-biostatistics-in-a-centralised-service-provision-csp-approach-to-clinical-development/ 2012-11-30T16:43:03+00:00 https://old.journalforclinicalstudies.com/social-media-advertising-and-minority-patient-recruitment/ 2012-11-30T16:40:34+00:00 https://old.journalforclinicalstudies.com/ophthalmic-medicines-development-challenges-and-opportunities/ 2012-11-30T16:38:43+00:00 https://old.journalforclinicalstudies.com/clinical-trials-in-egypt/ 2012-11-30T16:35:50+00:00 https://old.journalforclinicalstudies.com/local-medical-monitoring-in-russia-is-integral-to-overall-study-success/ 2012-11-30T16:33:59+00:00 https://old.journalforclinicalstudies.com/are-clinical-trials-agile-enough-what-pharma-can-learn-from-software-development/ 2012-11-30T16:28:29+00:00 https://old.journalforclinicalstudies.com/soothing-the-logistical-headache-of-clinical-trials/ 2012-11-30T16:25:07+00:00 https://old.journalforclinicalstudies.com/leveraging-cold-chain-management-to-improve-clinical-trial-efficiency/ 2012-11-30T16:22:07+00:00 https://old.journalforclinicalstudies.com/getting-results-with-elearning/ 2012-11-30T16:17:50+00:00 https://old.journalforclinicalstudies.com/prevention-of-cardiovascular-disease-with-omega-3-polyunsaturated-fatty-acids/ 2012-11-30T16:04:49+00:00 https://old.journalforclinicalstudies.com/a-new-era-in-alzheimers-research/ 2012-11-30T15:45:14+00:00 https://old.journalforclinicalstudies.com/potential-therapeutic-properties-of-human-mesenchymal-stem-cells-2/ 2012-11-30T15:18:47+00:00 https://old.journalforclinicalstudies.com/special-feature/ 2012-11-30T14:30:40+00:00 https://old.journalforclinicalstudies.com/what-exactly-is-health-2-0/ 2012-10-12T15:48:02+00:00 https://old.journalforclinicalstudies.com/then-and-now-is-clinical-trial-technology-provider-selection-and-implementation-becoming-easier/ 2012-09-25T14:50:14+00:00 https://old.journalforclinicalstudies.com/tipping-point-of-risk-based-site-monitoring-is-it-within-reach/ 2012-09-25T14:43:54+00:00 https://old.journalforclinicalstudies.com/cra-the-eclinical-persona/ 2012-09-25T14:38:46+00:00 https://old.journalforclinicalstudies.com/direct-to-the-epharma-consumer-in-the-age-of-connectivity/ 2012-09-25T14:31:00+00:00 https://old.journalforclinicalstudies.com/the-potential-use-of-vaccines-for-type-1-diabetes/ 2012-09-25T14:02:14+00:00 https://old.journalforclinicalstudies.com/risk-based-monitoring-the-new-regulatory-landscape-and-conjectures-on-the-future-of-clinical-trial-execution/ 2012-09-25T13:54:39+00:00 https://old.journalforclinicalstudies.com/developing-stem-cell-therapy-for-als-the-challenge-2/ 2012-09-25T13:23:36+00:00 https://old.journalforclinicalstudies.com/proactive-planning-for-subject-recruitment-and-retention-are-critical-to-modern-clinical-trial-success/ 2012-09-25T12:59:01+00:00 https://old.journalforclinicalstudies.com/maximising-the-role-of-statisticians-and-programmers-to-reduce-timelines-in-integrated-summaries-of-safety-and-effectiveness/ 2012-09-25T12:39:46+00:00 https://old.journalforclinicalstudies.com/paediatric-regulations-are-permanent-approaches-for-overcoming-the-challenges-of-paediatric-drug-development/ 2012-09-25T12:28:10+00:00 https://old.journalforclinicalstudies.com/good-distribution-practices-why-and-to-what-detail-gdp-contracts-between-sponsorsmanufacturers-and-distributors-are-needed/ 2012-09-25T11:01:54+00:00 https://old.journalforclinicalstudies.com/fda-expands-rules-on-the-disqualification-of-clinical-investigators/ 2012-09-25T10:54:51+00:00 https://old.journalforclinicalstudies.com/global-commercial-drug-supply-for-trials-how-to-achieve-long-term-success/ 2012-07-31T13:46:44+00:00 https://old.journalforclinicalstudies.com/london-2012-potential-logistical-challenges/ 2012-06-13T16:05:47+00:00